User profiles for "author:Gabriel Capella"
Gabriel CapellaVerified email at IDIBELL.CAT Cited by 31660 |
Peutz–Jeghers syndrome: a systematic review and recommendations for management
Peutz–Jeghers syndrome (PJS, MIM175200) is an autosomal dominant condition defined by
the development of characteristic polyps throughout the gastrointestinal tract and …
the development of characteristic polyps throughout the gastrointestinal tract and …
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer)
HFA Vasen, G Möslein, A Alonso, I Bernstein… - Journal of medical …, 2007 - jmg.bmj.com
Lynch syndrome (hereditary non-polyposis colorectal cancer) is characterised by the
development of colorectal cancer, endometrial cancer and various other cancers, and is …
development of colorectal cancer, endometrial cancer and various other cancers, and is …
Recent advances in cancer therapy: an overview
A Urruticoechea, R Alemany, J Balart… - Current …, 2010 - ingentaconnect.com
The landscape of cancer treatment has dramatically changed over the last four decades.
The age when surgery and radiotherapy were the only effective way to fight tumour growth …
The age when surgery and radiotherapy were the only effective way to fight tumour growth …
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
Lynch syndrome (LS) is characterised by the development of colorectal cancer, endometrial
cancer and various other cancers, and is caused by a mutation in one of the mismatch repair …
cancer and various other cancers, and is caused by a mutation in one of the mismatch repair …
Guidelines for the clinical management of familial adenomatous polyposis (FAP)
HFA Vasen, G Moeslein, A Alonso, S Aretz, I Bernstein… - Gut, 2008 - gut.bmj.com
Background: Familial adenomatous polyposis (FAP) is a well-described inherited syndrome,
which is responsible for< 1% of all colorectal cancer (CRC) cases. The syndrome is …
which is responsible for< 1% of all colorectal cancer (CRC) cases. The syndrome is …
Analysis of Adenomatous Polyposis Coli Promoter Hypermethylation in Human Cancer
M Esteller, A Sparks, M Toyota, M Sanchez-Cespedes… - Cancer research, 2000 - AACR
Germ-line mutations in the tumor suppressor gene APC are associated with hereditary
familial adenomatous polyposis (FAP), and somatic mutations are common in sporadic …
familial adenomatous polyposis (FAP), and somatic mutations are common in sporadic …
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21
A Tenesa, SM Farrington, JGD Prendergast… - Nature …, 2008 - nature.com
In a genome-wide association study to identify loci associated with colorectal cancer (CRC)
risk, we genotyped 555,510 SNPs in 1,012 early-onset Scottish CRC cases and 1,012 …
risk, we genotyped 555,510 SNPs in 1,012 early-onset Scottish CRC cases and 1,012 …
Inactivation of the DNA Repair Gene O6-Methylguanine-DNA Methyltransferase by Promoter Hypermethylation Is Associated with G to A Mutations in K-ras in …
Abstract O 6-Methylguanine DNA methyltransferase (MGMT) is a DNA repair protein that
removes mutagenic and cytotoxic adducts from the O 6 position of guanine. O 6 …
removes mutagenic and cytotoxic adducts from the O 6 position of guanine. O 6 …
[PDF][PDF] Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer
Gene Expression Signature to Improve Prognosis Prediction of Stage II and III Colorectal
Cancer Page 1 Gene Expression Signature to Improve Prognosis Prediction of Stage II and III …
Cancer Page 1 Gene Expression Signature to Improve Prognosis Prediction of Stage II and III …
Hypermethylation-associated Inactivation of p14ARF Is Independent of p16INK4a Methylation and p53 Mutational Status
The INK4a/ARF locus encodes two cell cycle-regulatory proteins, p16 INK4a and p14 ARF,
which share an exon using different reading frames. p14 ARF antagonizes MDM2 …
which share an exon using different reading frames. p14 ARF antagonizes MDM2 …